MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q3
hinzugefügt 19.11.2025
OpGen Kurshistorie 2011-2025 | OPGN
Kurshistorie Jährlich OpGen
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.96 | 2.54 | 1.53 | 0.88 | 2.17 | 1.57 | 28.6 | 77 | 570 | 875 | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 875 | 0.88 | 156 |
Kurshistorie anderer Aktien in der Diagnostik & Forschung
| Name | Kurshistorie | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Akumin
AKU
|
0.84 | - | -17.87 % | $ 25.9 M |  Canada |
|
Centogene N.V.
CNTG
|
0.38 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Brainsway Ltd.
BWAY
|
8.85 | $ 19.34 | 0.26 % | $ 99.4 M |  Israel |
 |
Burning Rock Biotech Limited
BNR
|
8.43 | $ 20.47 | -3.72 % | $ 221 M |  China |
 |
Accelerate Diagnostics
AXDX
|
0.49 | - | -61.36 % | $ 2.46 M |  USA |
 |
Biocept
BIOC
|
0.35 | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
0.39 | - | 0.22 % | $ 16.8 M | USA |
 |
Co-Diagnostics
CODX
|
1.19 | $ 0.23 | -5.81 % | $ 6.75 M | USA |
 |
Castle Biosciences
CSTL
|
25.5 | $ 39.52 | -1.42 % | $ 1.1 B | USA |
 |
BioNano Genomics
BNGO
|
2.79 | $ 1.52 | -0.28 % | $ 1.93 M | USA |
 |
DarioHealth Corp.
DRIO
|
1.53 | $ 10.11 | 0.67 % | $ 287 M | Israel |
 |
DexCom
DXCM
|
126 | $ 67.39 | -0.05 % | $ 26 B | USA |
 |
Danaher Corporation
DHR
|
208 | $ 229.66 | -0.59 % | $ 168 B | USA |
 |
Exact Sciences Corporation
EXAS
|
50.3 | $ 101.56 | 0.02 % | $ 18.8 B | USA |
 |
Enzo Biochem
ENZ
|
1.13 | - | -8.98 % | $ 14.8 K | USA |
 |
Fulgent Genetics
FLGT
|
15.4 | $ 26.73 | -1.06 % | $ 808 M | USA |
 |
Global Cord Blood Corporation
CO
|
2.5 | - | - | $ 399 M | China |
 |
Genetic Technologies Limited
GENE
|
1.44 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
0.87 | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
1.3 | - | -11.32 % | $ 2.94 M | USA |
 |
CareDx, Inc
CDNA
|
9.69 | $ 19.42 | -1.57 % | $ 1.04 B | USA |
 |
Celcuity
CELC
|
10.1 | $ 102.03 | -0.57 % | $ 4.03 B | USA |
 |
Anixa Biosciences
ANIX
|
2.22 | $ 3.22 | -5.85 % | $ 103 K | USA |
 |
Heska Corporation
HSKA
|
81.6 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
3.36 | - | -20.0 % | $ 1.06 M | USA |
 |
IQVIA Holdings
IQV
|
197 | $ 226.17 | 0.07 % | $ 41 B | USA |
 |
Guardant Health
GH
|
47.6 | $ 103.5 | 1.09 % | $ 12.7 B | USA |
 |
Aspira Women's Health
AWH
|
0.39 | - | -6.19 % | $ 10.5 M | USA |
 |
Illumina
ILMN
|
103 | $ 134.92 | -0.3 % | $ 21.5 B | USA |
 |
Charles River Laboratories International
CRL
|
166 | $ 202.8 | -0.53 % | $ 10.4 B | USA |
 |
Myriad Genetics
MYGN
|
10.7 | $ 6.44 | -1.68 % | $ 583 M | USA |
 |
ENDRA Life Sciences
NDRA
|
4.1 | $ 5.0 | -1.96 % | $ 2.68 M | USA |
 |
Neogen Corporation
NEOG
|
4.7 | $ 7.05 | -1.33 % | $ 1.53 B | USA |
 |
National Research Corporation
NRC
|
41.1 | $ 18.65 | - | $ 458 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
172 | $ 175.92 | 0.02 % | $ 19.5 B | USA |
|
Biodesix
BDSX
|
0.71 | $ 6.66 | -2.35 % | $ 864 M | USA |
 |
Motus GI Holdings
MOTS
|
0.64 | - | -34.28 % | $ 263 K | Israel |
 |
Laboratory Corporation of America Holdings
LH
|
252 | $ 253.39 | -0.35 % | $ 21.3 B | USA |
 |
ICON Public Limited Company
ICLR
|
201 | $ 182.42 | -0.69 % | $ 15 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
457 | $ 685.62 | -0.37 % | $ 56.5 B | USA |
 |
Lantheus Holdings
LNTH
|
93.4 | $ 66.24 | -0.66 % | $ 4.58 B | USA |
 |
Mettler-Toledo International
MTD
|
1.41 K | $ 1 418.11 | - | $ 30.1 B |  Schweiz |
 |
Agilent Technologies
A
|
139 | $ 138.02 | -0.18 % | $ 42 B | USA |
 |
Pacific Biosciences of California
PACB
|
5.57 | $ 1.79 | -5.05 % | $ 454 M | USA |
 |
Biomerica
BMRA
|
3.13 | $ 2.7 | 1.89 % | $ 6.2 M | USA |
 |
Bioventus
BVS
|
5.6 | $ 7.35 | -0.41 % | $ 460 M | USA |
 |
NeoGenomics
NEO
|
12.1 | $ 12.32 | 0.12 % | $ 1.56 B | USA |